Vectura Group plc (LSE: VEC) ("Vectura", "the Group"), an industry-leading device and formulation business for inhaled airways products, today announces it is progressing the development of a branded ...

September 20, 2010 (Barcelona, Spain) — Adding the anticholinergic agent tiotropium bromide (Spiriva, Boehringer-Ingelheim and Pfizer), approved for the treatment of chronic obstructive pulmonary ...

Details concerning the Tiotropium Bromide combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Tiotropium bromide is a new quaternary ammonium compound with anticholinergic properties specific for muscarinic receptors (M1, M2, and M3) in humans. [1] Because acetylcholine modulates bronchial ...

SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...

The benefits of pharmacotherapy with tiotropium HandiHaler 18 μg for patients with chronic obstructive pulmonary disease (COPD) have been previously demonstrated. However, few data exist regarding the ...

DUBLIN--(BUSINESS WIRE)--The "Investigation Report on China's Tiotropium Bromide Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Tiotropium Bromide, developed by ...

MUMBAI: India’s Patent Office has revoked a patent on asthma drug, Spiriva (tiotropium bromide monohydrate) held by German major Boehringer Ingelheim on an opposition filed by generic company, Cipla.

Research and Markets (http://www.researchandmarkets.com/research/rvchgj/investigation) has announced the addition of the "Investigation Report on China Tiotropium ...